Jefferies Financial Group Inc. Lantheus Holdings, Inc. Transaction History

Jefferies Financial Group Inc.

  • $13.5 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$51.07 - $68.26 $574,128 - $767,378
11,242 Added 273.0%
15,360 $956,000
Q4 2023

Feb 13, 2024
BUY
$55.6 - $77.89 $228,960 - $320,751
4,118 New
4,118 $255,000
Q1 2023

May 15, 2023
BUY
$47.76 - $82.86 $2.45 Million - $4.25 Million
51,343 Added 358.89%
65,649 $5.42 Million
Q4 2022

Sep 21, 2023
BUY
$48.76 - $77.67 $470,338 - $749,204
9,646 New
9,646 $491,000
Q4 2022

Feb 14, 2023
BUY
$48.76 - $77.67 $697,560 - $1.11 Million
14,306 New
14,306 $729,000

Others Institutions Holding LNTH

# of Institutions
539
Shares Held
69.9M
Call Options Held
651K
Put Options Held
459K
View Full List

About Lantheus Holdings, Inc.

LNTH Quotes by TradingView
  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $5.63B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Jefferies Financial Group Inc. Portfolio

Follow Jefferies Financial Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email